| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer
|
De Iuliis, Francesca
|
|
2017
|
17 |
1 |
p. 34-40
7 p.
|
artikel
|
| 2 |
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer
|
Jasra, Sakshi
|
|
2017
|
17 |
1 |
p. e37-e41
nvt p.
|
artikel
|
| 3 |
Carcinosarcoma of the Breast: An Aggressive Subtype of Metaplastic Cancer. Report of a Rare Case in a Young BRCA-1 Mutated Woman
|
Ghilli, Matteo
|
|
2017
|
17 |
1 |
p. e31-e35
nvt p.
|
artikel
|
| 4 |
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients
|
Foglietta, Jennifer
|
|
2017
|
17 |
1 |
p. 11-17
7 p.
|
artikel
|
| 5 |
Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis
|
Morikawa, Aki
|
|
2017
|
17 |
1 |
p. 23-28
6 p.
|
artikel
|
| 6 |
Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
|
Takahashi, Hiroyo
|
|
2017
|
17 |
1 |
p. 61-69.e3
68940 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2017
|
17 |
1 |
p. A1-
1 p.
|
artikel
|
| 8 |
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5
|
Smith II, John W.
|
|
2017
|
17 |
1 |
p. 48-54.e3
53953 p.
|
artikel
|
| 9 |
Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer
|
Park, Sungmin
|
|
2017
|
17 |
1 |
p. e19-e29
nvt p.
|
artikel
|
| 10 |
Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer
|
Lee, Jeeyeon
|
|
2017
|
17 |
1 |
p. 70-75
6 p.
|
artikel
|
| 11 |
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens
|
Gao, Jennifer J.
|
|
2017
|
17 |
1 |
p. 76-78
3 p.
|
artikel
|
| 12 |
Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue
|
Zhu, Wenlian
|
|
2017
|
17 |
1 |
p. e11-e18
nvt p.
|
artikel
|
| 13 |
Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities
|
Rodhouse, Christine
|
|
2017
|
17 |
1 |
p. 18-22
5 p.
|
artikel
|
| 14 |
Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer
|
Tecalco-Cruz, Angeles C.
|
|
2017
|
17 |
1 |
p. 1-10
10 p.
|
artikel
|
| 15 |
Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution
|
Edenfield, Jessica
|
|
2017
|
17 |
1 |
p. e1-e10
nvt p.
|
artikel
|
| 16 |
Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation
|
Wilkinson, J. Ben
|
|
2017
|
17 |
1 |
p. 55-60
6 p.
|
artikel
|
| 17 |
Physical Effects of Unilateral Mastectomy on Spine Deformity
|
Serel, Savaş
|
|
2017
|
17 |
1 |
p. 29-33
5 p.
|
artikel
|
| 18 |
Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index
|
Ono, Makiko
|
|
2017
|
17 |
1 |
p. 41-47
7 p.
|
artikel
|
| 19 |
Table of Contents
|
|
|
2017
|
17 |
1 |
p. A3-A5
nvt p.
|
artikel
|
Tijdschrift beschrijving